…REPORT FROM THE AHA/ASA INTERNATIONAL STROKE CONFERENCE – A retrospective analysis of data from the Vitamin Intervention for Stroke Prevention (VISP) trial has examined the impact of patient adherence on clinical outcomes (Ovbiagele et al. Abstract P466). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…REPORT FROM THE AHA/ASA INTERNATIONAL STROKE CONFERENCE – Patients who do not respond to low-dose acetylsalicylic acid (ASA) for secondary stroke prevention are unlikely to respond to a higher dose, according to researchers at the University of Buffalo, NY (Gengo et al. Abstract 85). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…For multiple sclerosis patients who fail to respond to a first-line disease-modifying treatment (DMT), switching to another DMT is a generally effective strategy, according to an analysis by U.S. and Italian researchers (Gajofatto et al. Mult Scler 2009;15:50-58). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…A prospective cohort study in Denmark has found that head injury is not associated with an increased risk of developing multiple sclerosis (Pfleger et al. Mult Scler 2008; epublished November 21, 2008). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…
…newsletter with Continue…